secwatch.observer — SEC 8-K summary
======================================

Issuer:     eFFECTOR Therapeutics, Inc. (—)
CIK:        0001828522
Form:       8-K
Filed at:   2023-08-04T23:59:59+00:00
Accession:  0001193125-23-203837
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

eFFECTOR Therapeutics receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------------

- Received Nasdaq letter on July 31, 2023; common stock bid price below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until January 29, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by Jan 29, 2024, may be eligible for an additional 180-day period if other listing standards are met.
- Stock continues trading on Nasdaq Capital Market under symbol EFTR during the cure period.
- Company will monitor bid price and consider options, including a potential reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828522/000119312523203837/0001193125-23-203837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828522/000119312523203837/d543614d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-203837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer